Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
Procalcitonin (PCT)-guided antibiotic stewardship (ABS) has been shown to reduce antibiotics (ABxs), with lower side-effects and an improvement in clinical outcomes. The aim of this experts workshop was to derive a PCT algorithm ABS for easier implementation into clinical routine across different clinical settings. Clinical evidence and practical experience with PCT-guided ABS was analyzed and discussed, with a focus on optimal PCT use in the clinical context and increased adherence to PCT protocols. Using a Delphi process, the experts group reached consensus on different PCT algorithms based on clinical severity of the patient and probability of bacterial infection. The group agreed that there is strong evidence that PCT-guided ABS supports individual decisions on initiation and duration of ABx treatment in patients with acute respiratory infections and sepsis from any source, thereby reducing overall ABx exposure and associated side effects, and improving clinical outcomes. To simplify practical application, the expert group refined the established PCT algorithms by incorporating severity of illness and probability of bacterial infection and reducing the fixed cut-offs to only one for mild to moderate and one for severe disease (0.25 μg/L and 0.5 μg/L, respectively). Further, guidance on interpretation of PCT results to initiate, withhold or discontinue ABx treatment was included. A combination of clinical patient assessment with PCT levels in well-defined ABS algorithms, in context with continuous education and regular feedback to all ABS stakeholders, has the potential to improve the diagnostic and therapeutic management of patients suspected of bacterial infection, thereby improving ABS effectiveness.
ABx stewardship, bacterial infection, biomarker, procalcitonin, respiratory tract infections, sepsis
1308-1318
Schuetz, Philipp
ad48627c-d757-419c-bda1-a44b620bdd25
Beishuizen, Albertus
0403a954-d9f1-4254-b35f-a50efb7345b7
Broyles, Michael
dfe351de-c0ce-4de3-a280-393659657f06
Ferrer, Ricard
2b0bab57-cf1f-4025-80c9-1fbb054c8ac0
Gavazzi, Gaetan
69357d64-a90a-4aad-b109-636d60b46370
Gluck, Eric Howard
7b223515-59d7-4afd-8fc7-3bd990df04cc
González Del Castillo, Juan
9a8034cc-b9ae-4571-a96c-b916b61a1095
Jensen, Jens Ulrik
10252f2a-a577-49dd-a8cd-385070455a29
Kanizsai, Peter Laszlo
67aa0450-caf7-4ecf-a7fb-794094df4837
Kwa, Andrea Lay Hoon
bdc00781-1134-4972-b071-83b48e0c0b64
Krueger, Stefan
37fee818-f2f5-48df-ba0a-f7567e890e8e
Luyt, Charles Edouard
37b0a767-fa7d-453c-a0c9-ca546e4430cd
Oppert, Michael
abbeaf4b-6714-4162-af7d-f39397d72b46
Plebani, Mario
748a0f7b-ca3c-49c8-96a8-e339562d2a9e
Shlyapnikov, Sergey A.
8a77a7f6-1ce0-42d7-9d1d-42f38f8b5cbc
Toccafondi, Giulio
2f137c15-b2b7-4cbb-9d31-1e68c3c92360
Townsend, Jennifer
99f6cd8a-f09a-43a0-9542-72bbd9f7a425
Welte, Tobias
6607095c-9471-4022-b144-f683c6ac8f58
Saeed, Kordo
87cb67e5-71e8-4759-bf23-2ea00ebd8b39
September 2019
Schuetz, Philipp
ad48627c-d757-419c-bda1-a44b620bdd25
Beishuizen, Albertus
0403a954-d9f1-4254-b35f-a50efb7345b7
Broyles, Michael
dfe351de-c0ce-4de3-a280-393659657f06
Ferrer, Ricard
2b0bab57-cf1f-4025-80c9-1fbb054c8ac0
Gavazzi, Gaetan
69357d64-a90a-4aad-b109-636d60b46370
Gluck, Eric Howard
7b223515-59d7-4afd-8fc7-3bd990df04cc
González Del Castillo, Juan
9a8034cc-b9ae-4571-a96c-b916b61a1095
Jensen, Jens Ulrik
10252f2a-a577-49dd-a8cd-385070455a29
Kanizsai, Peter Laszlo
67aa0450-caf7-4ecf-a7fb-794094df4837
Kwa, Andrea Lay Hoon
bdc00781-1134-4972-b071-83b48e0c0b64
Krueger, Stefan
37fee818-f2f5-48df-ba0a-f7567e890e8e
Luyt, Charles Edouard
37b0a767-fa7d-453c-a0c9-ca546e4430cd
Oppert, Michael
abbeaf4b-6714-4162-af7d-f39397d72b46
Plebani, Mario
748a0f7b-ca3c-49c8-96a8-e339562d2a9e
Shlyapnikov, Sergey A.
8a77a7f6-1ce0-42d7-9d1d-42f38f8b5cbc
Toccafondi, Giulio
2f137c15-b2b7-4cbb-9d31-1e68c3c92360
Townsend, Jennifer
99f6cd8a-f09a-43a0-9542-72bbd9f7a425
Welte, Tobias
6607095c-9471-4022-b144-f683c6ac8f58
Saeed, Kordo
87cb67e5-71e8-4759-bf23-2ea00ebd8b39
Schuetz, Philipp, Beishuizen, Albertus, Broyles, Michael, Ferrer, Ricard, Gavazzi, Gaetan, Gluck, Eric Howard, González Del Castillo, Juan, Jensen, Jens Ulrik, Kanizsai, Peter Laszlo, Kwa, Andrea Lay Hoon, Krueger, Stefan, Luyt, Charles Edouard, Oppert, Michael, Plebani, Mario, Shlyapnikov, Sergey A., Toccafondi, Giulio, Townsend, Jennifer, Welte, Tobias and Saeed, Kordo
(2019)
Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use.
Clinical Chemistry and Laboratory Medicine, 57 (9), .
(doi:10.1515/cclm-2018-1181).
Abstract
Procalcitonin (PCT)-guided antibiotic stewardship (ABS) has been shown to reduce antibiotics (ABxs), with lower side-effects and an improvement in clinical outcomes. The aim of this experts workshop was to derive a PCT algorithm ABS for easier implementation into clinical routine across different clinical settings. Clinical evidence and practical experience with PCT-guided ABS was analyzed and discussed, with a focus on optimal PCT use in the clinical context and increased adherence to PCT protocols. Using a Delphi process, the experts group reached consensus on different PCT algorithms based on clinical severity of the patient and probability of bacterial infection. The group agreed that there is strong evidence that PCT-guided ABS supports individual decisions on initiation and duration of ABx treatment in patients with acute respiratory infections and sepsis from any source, thereby reducing overall ABx exposure and associated side effects, and improving clinical outcomes. To simplify practical application, the expert group refined the established PCT algorithms by incorporating severity of illness and probability of bacterial infection and reducing the fixed cut-offs to only one for mild to moderate and one for severe disease (0.25 μg/L and 0.5 μg/L, respectively). Further, guidance on interpretation of PCT results to initiate, withhold or discontinue ABx treatment was included. A combination of clinical patient assessment with PCT levels in well-defined ABS algorithms, in context with continuous education and regular feedback to all ABS stakeholders, has the potential to improve the diagnostic and therapeutic management of patients suspected of bacterial infection, thereby improving ABS effectiveness.
Text
[Clinical Chemistry and Laboratory Medicine (CCLM)] Procalcitonin (PCT)-guided antibiotic stewardship an international experts consensus on optimized clinical use
- Version of Record
More information
Accepted/In Press date: 16 December 2018
e-pub ahead of print date: 6 February 2019
Published date: September 2019
Keywords:
ABx stewardship, bacterial infection, biomarker, procalcitonin, respiratory tract infections, sepsis
Identifiers
Local EPrints ID: 428669
URI: http://eprints.soton.ac.uk/id/eprint/428669
ISSN: 1434-6621
PURE UUID: 11958bd8-2c76-416e-9244-3d2e55a24fb0
Catalogue record
Date deposited: 06 Mar 2019 17:30
Last modified: 16 Mar 2024 04:41
Export record
Altmetrics
Contributors
Author:
Philipp Schuetz
Author:
Albertus Beishuizen
Author:
Michael Broyles
Author:
Ricard Ferrer
Author:
Gaetan Gavazzi
Author:
Eric Howard Gluck
Author:
Juan González Del Castillo
Author:
Jens Ulrik Jensen
Author:
Peter Laszlo Kanizsai
Author:
Andrea Lay Hoon Kwa
Author:
Stefan Krueger
Author:
Charles Edouard Luyt
Author:
Michael Oppert
Author:
Mario Plebani
Author:
Sergey A. Shlyapnikov
Author:
Giulio Toccafondi
Author:
Jennifer Townsend
Author:
Tobias Welte
Author:
Kordo Saeed
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics